• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Glucose monitor maker Know Labs expands leadership team

May 24, 2022 By Sean Whooley

Know Labs KnowU Uband
[Image from Know Labs]
Non-invasive glucose monitor developer Know Labs (OTCQB:KNWN) announced today that it added two executives to its leadership team.

Seattle-based Know Labs — which aims to make the first non-invasive glucose monitor cleared by the FDA — added Steven Kent as its new chief product officer, along with Peter Conley as its CFO and SVP of intellectual property.

“Pete and Steve bring tremendous expertise that will help us refine and execute our IP strategy, product innovation, and machine learning progress,” Know Labs CEO Phil Bosua said in a news release. “By strengthening our executive leadership team, we are better positioned to tackle the milestones needed for the FDA clearance process.”

The company designed its Bio-RFID technology to use spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It can be integrated into wearable, mobile or bench-top form factors. Know Labs’ first application of the technology comes in the form of a non-invasive glucose monitor.

Conley has over 34 years of corporate finance and equity capital markets experience, having most recently served as senior managing director and head of intellectual property banking at Boustead Securities. He previously co-founded and served as COO of ipCreate.

Kent joins Know Labs with more than 10 years of experience as an inventor, entrepreneur and leader in medical and health-focused consumer systems. He was most recently head of health partnerships and corporate strategy at Oura and previously founded and served as CEO of Invicta Medical.

“It is exciting to witness our organization grow,” Know Labs CMO Dr. James Anderson said. “I’ve been through this process several times in my career. As we get closer to FDA submission and clearance, the amount of work increases across multiple disciplines; and this requires expertise in each discipline. Having experienced and highly qualified individuals is critical for our success.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: Know Labs, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS